Hematology (Grove) Flashcards

(39 cards)

1
Q

Hodgkin’s lymphoma treatment goal

A

Cure; use high dose chemo followed by autologous stem cell transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for hodgekin’s lymphoma

A

viral exposure (Epstein-Barr virus), impaired immune function (solid organ transplant, HIV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hodgkin’s lymphoma chemo regimen

A

ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) (cardiotoxicity and pulmonary toxicity) or AAVD (6 cycles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which type of non-Hodgkin’s lymphoma is the most prevalent?

A

B cell (85%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How to diagnose NHL and HL

A

excisional biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

follicular lymphoma treatment

A

type of NHL
slow growing; treat symptoms only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is Richter’s transformation?

A

transformation of slow-growing NHL into an aggressive NHL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the median time from diagnosis of low-grade NHL to transformation to DLBCL (diffuse large B Cell Lymphoma)?

A

~5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the treatment for DLBCL

A

R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, presnisolone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the treatment for DLBCL in high risk patients

A

Pola + R + CHP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should be done before initiating rituximab (anti CD-20) in a patient with NHL?

A

check a hepatitis B surface antigen and hep B core antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How to pre-treat for HepB reactivation in NHL

A

entecavir 0.5mg daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NHL treatment options

A

1st: rituximab, 2nd: CAR-T, 3rd: Bispecific t-cell engagers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the treatment for cytokine release syndrome?

A

Tocilizumab (anti IL-6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is ICANS?

A

Immune effector cell-associated neurotoxicity syndrome

mainly presents as confusion/ altered mental status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How to treat ICANS?

A

corticosteroids!

17
Q

multiple myeloma patho

A

abnormal plasma cells infiltrating the bone marrow (m-protein)

18
Q

Multiple Myeloma (MM) presentation

A

C- calcium >11.5mg/dL (constipation, altered mental status)
R- renal dysfunction SCr > 2 mg/dL or CrCl < 40 mL/min
A- anemia <10g/dL (or 2g/dL below normal)
B- bone; one or more osteolytic lesions

19
Q

multiple myeloma treatment

A

3 drug regimen, then stem cell transplant if possible

20
Q

3 drug regimen for MM

A

thalidomide derivative, steroids, proteasome inhibitor (bortezomib) (causes apoptosis of cancer cells)

21
Q

MM treatment goals?

A

incurable; prolong survival with stem cell rescue. use 3 drug regimen

22
Q

What are the chronic leukemias?

A

chronic myeloid Leukemia (CML)
chronic lymphocytic leukemia (CLL)

23
Q

patho of CML

A

Philadelphia chromosome (BCR-ABL) oncogene

24
Q

CML presentation

A
  • leukocytosis (as high as 1 mil WBCs causing leukostasis) = medical emergency
  • can cause stroke and/or organ dysfunction
25
CML treatment
- tyrosine kinase inhibitors - cure with stem cell transplant - TKIs: Imatinib, Ponatinib (for T315A mutation)
26
Imatinib considerations
- need to be compliant! - metabolized CYP3A4 - nausea and rash
27
Dasatinib considerations
avoid acid reducers may cause fluid retention
28
Nilotinib considerations
may cause metabolic syndrome and QTC prolongation
29
Bosutinib considerations
may cause diarrhea and GI toxicity
30
Ponatinib considerations
may cause ischemia, vascular occlusion, and hypertension
31
chronic lymphoid leukemia patho
loss of apoptosis and lymphocyte accumulation
32
CLL treatment principles
only treat if symptomatic - tx reserved for stage III or IV disease
33
CLL treatment
BTK inhibitor (___BRUTinib) (indefinite) and venetoclax x 1 year
34
AML presentation
pancytopenia, bone pain, gum hypertrophy
35
AML diagnosis
- through bone marrow biopsy - greater than 20% blasts (immature cells)
36
AML treatment principles
induce remission and prevent relapse (do a bone marrow biopsy before and after treatment)
37
venetoclax considerations
tumor lysis syndrome
38
ALL treatment considerations
can hide in brain or testes (can cause testes to enlarge)
39
ALL CNS treatment
intrathecal methotrexate or cytarabine